Empagliflozin and linagliptin
Empagliflozin and linagliptin is a combination of two medicines used in the management of type 2 diabetes. Empagliflozin is an SGLT2 inhibitor, which helps the kidneys remove glucose through urine, while linagliptin is a DPP-4 inhibitor that supports the body's insulin response after meals and can reduce glucose released by the liver. Treatment choices should be guided by a qualified prescriber.
In Australia, all represented products require a prescription.
Our current empagliflozin and linagliptin option
We currently offer Glyxambi as film-coated tablets in one strength: 10 mg + 5 mg. Pack sizes are 30, 60, 90 and 180 tablets, allowing you to select the quantity that suits your prescribed ongoing supply.
- Product: Glyxambi
- Form: Film-coated tablet
- Strength: 10 mg + 5 mg
- Available pack sizes: 30, 60, 90 or 180 tablets
- Price range: A$155.04 to A$848.16
- Lowest listed tablet price: A$4.71 per tablet, based on the 180-tablet pack priced at A$848.16
The 180-tablet pack is the best-value package currently listed by tablet price. A larger pack may be convenient for an established prescription, while smaller quantities may suit other purchasing needs. Follow the directions provided by your prescriber and pharmacist rather than changing your dose or treatment schedule yourself.
Ordering, payment and delivery
You can order from us online, and we accept Visa, Mastercard, Bitcoin and USDT. At checkout, you will see the final total and available delivery options for your destination.
We offer Express delivery for A$45.58, with tracking and an estimated delivery time of 4-7 days. Standard delivery is A$22.78, is not tracked, and has an estimated delivery time of 14-21 days. Free delivery may apply when the applicable threshold is met; the threshold is shown at checkout.